These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16381402)

  • 21. Peginterferon and ribavirin for hepatitis C.
    Duggan AE; Duggan JM
    N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17377169
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapy.
    Jacobson IM
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):921-30. PubMed ID: 19362605
    [No Abstract]   [Full Text] [Related]  

  • 23. [Management of chronic hepatitis C which failed to respond to previous treatment].
    Bronowicki JP; Nani A; Barraud H
    Gastroenterol Clin Biol; 2009 Apr; 33(4):345-52. PubMed ID: 19349132
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimizing the current therapy for chronic hepatitis C virus: peginterferon and ribavirin dosing and the utility of growth factors.
    Shiffman ML
    Clin Liver Dis; 2008 Aug; 12(3):487-505, vii. PubMed ID: 18625425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High dose repeat therapy in previously treated patients with chronic hepatitis C].
    Hoepffner N; Paul KA; Nikodem AB; Teuber G
    Dtsch Med Wochenschr; 2006 Mar; 131(11):543-4. PubMed ID: 16538557
    [No Abstract]   [Full Text] [Related]  

  • 26. [PEG-interferons: significance for the treatment of viral hepatitis B and C].
    Wedemeyer H; Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S68-75. PubMed ID: 11450618
    [No Abstract]   [Full Text] [Related]  

  • 27. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
    Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678
    [No Abstract]   [Full Text] [Related]  

  • 28. [Optimization of the method of treatment of chronic viral hepatitis C with pegylated interferon-alfa and ribavirin].
    Juszczyk J
    Przegl Epidemiol; 2006; 60(2):237-46. PubMed ID: 16964674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Taylor LE; Rich JD; Tashima KT
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15564553
    [No Abstract]   [Full Text] [Related]  

  • 30. PEG-IFN, RBV dosing during chronic HCV re-treatment.
    Highleyman L
    IAPAC Mon; 2007 Feb; 13(2):55. PubMed ID: 17948601
    [No Abstract]   [Full Text] [Related]  

  • 31. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Gholam PM
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15570682
    [No Abstract]   [Full Text] [Related]  

  • 32. [APRICOT Study evaluated. Surprisingly high virologic response in HIV-HCV coinfection].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():74-5. PubMed ID: 15373058
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pegylated interferon α-2a and ribavirin antiviral therapy efficacy for treating chronic hepatitis C and its effects on psychological status of patients].
    An J; Qiao J; Ni W
    Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):772-3. PubMed ID: 25558497
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical practice. Chronic hepatitis C infection.
    Rosen HR
    N Engl J Med; 2011 Jun; 364(25):2429-38. PubMed ID: 21696309
    [No Abstract]   [Full Text] [Related]  

  • 35. Pushing the treatment envelope for chronic hepatitis C--is more necessarily better?
    Lutchman G; Ghany M
    Hepatology; 2005 Feb; 41(2):234-6. PubMed ID: 15657958
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon for hepatitis C patients with psychiatric disorders.
    Rifai MA; Bozorg B; Rosenstein DL
    Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic hepatitis C virus infection.
    Flamm SL
    JAMA; 2003 May; 289(18):2413-7. PubMed ID: 12746366
    [No Abstract]   [Full Text] [Related]  

  • 38. Peginterferons in hepatitis C virus: virological, pharmacokinetic, and clinical implications. Introduction.
    Keeffe EB
    Semin Liver Dis; 2003; 23 Suppl 1():1-2. PubMed ID: 12934161
    [No Abstract]   [Full Text] [Related]  

  • 39. Intrahepatic interferon-stimulated gene responses: can they predict treatment responses in chronic hepatitis C infection?
    Shackel NA; McCaughan GW
    Hepatology; 2007 Nov; 46(5):1326-8. PubMed ID: 17969041
    [No Abstract]   [Full Text] [Related]  

  • 40. [Peginterferon alpha-2a and ribavirin for treating chronic hepatitis C patients with persistent normal aminotransferase levels].
    Jiang TJ; Fan R; Xie YX; Zhao P; Zhang X; Zhao M; Zhou ZP; He J
    Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):307-8. PubMed ID: 18423159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.